14例硼替佐米致心力衰竭文獻(xiàn)分析
發(fā)布時(shí)間:2018-11-06 17:48
【摘要】:目的:分析硼替佐米致心力衰竭的發(fā)生規(guī)律及特點(diǎn),為安全用藥提供參考。方法:檢索國內(nèi)外硼替佐米致心力衰竭個(gè)案報(bào)道文獻(xiàn)進(jìn)行分析。結(jié)果:共檢索到硼替佐米致心力衰竭個(gè)案報(bào)道11篇,涉及14例患者,男性8例,女性6例,年齡≥60歲的老年患者7例,有心血管疾病基礎(chǔ)疾病及接受過蒽環(huán)類藥物治療分別有5例,有7例在第4次化療周期后發(fā)生心力衰竭。硼替佐米致心力衰竭臨床表現(xiàn)主要為呼吸困難,心胸比率增大,左、右室內(nèi)徑增加,LVEF下降,BNP增高。結(jié)論:有心血管疾病基礎(chǔ)疾病及蒽環(huán)類藥物使用史可能更易發(fā)生心力衰竭,應(yīng)加強(qiáng)硼替佐米致心力衰竭監(jiān)測(cè),重點(diǎn)防治,減少其發(fā)生。
[Abstract]:Objective: to analyze the occurrence and characteristics of bortezomib induced heart failure in order to provide reference for safe drug use. Methods: to search the literature of bortezomib induced heart failure at home and abroad. Results: a total of 11 cases of bortezomib induced heart failure were reported, involving 14 patients, 8 males, 6 females, 7 elderly patients aged more than 60 years. There were 5 cases of cardiovascular disease and 5 cases of anthracycline treatment, and 7 cases developed heart failure after the fourth chemotherapy cycle. The clinical manifestations of bortezomib in heart failure were dyspnea, cardiothoracic ratio, left and right ventricular diameter, LVEF and BNP. Conclusion: heart failure may be more likely to occur in patients with underlying cardiovascular diseases and anthracycline use. The monitoring of heart failure caused by bortezomib should be strengthened to focus on prevention and treatment and to reduce the occurrence of heart failure.
【作者單位】: 安徽省蚌埠市第三人民醫(yī)院藥學(xué)部;
【分類號(hào)】:R541.6
[Abstract]:Objective: to analyze the occurrence and characteristics of bortezomib induced heart failure in order to provide reference for safe drug use. Methods: to search the literature of bortezomib induced heart failure at home and abroad. Results: a total of 11 cases of bortezomib induced heart failure were reported, involving 14 patients, 8 males, 6 females, 7 elderly patients aged more than 60 years. There were 5 cases of cardiovascular disease and 5 cases of anthracycline treatment, and 7 cases developed heart failure after the fourth chemotherapy cycle. The clinical manifestations of bortezomib in heart failure were dyspnea, cardiothoracic ratio, left and right ventricular diameter, LVEF and BNP. Conclusion: heart failure may be more likely to occur in patients with underlying cardiovascular diseases and anthracycline use. The monitoring of heart failure caused by bortezomib should be strengthened to focus on prevention and treatment and to reduce the occurrence of heart failure.
【作者單位】: 安徽省蚌埠市第三人民醫(yī)院藥學(xué)部;
【分類號(hào)】:R541.6
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王慧涵;廖愛軍;劉卓剛;王曉彬;李迎春;楊威;張嶸;張新剛;;硼替佐米聯(lián)合地塞米松治療復(fù)發(fā)及難治性多發(fā)性骨髓瘤的臨床研究[J];中國醫(yī)科大學(xué)學(xué)報(bào);2008年01期
2 李增軍;鄒德慧;劉慶珍;邱錄貴;;硼替佐米治療繼發(fā)性漿細(xì)胞白血病1例并文獻(xiàn)復(fù)習(xí)[J];臨床血液學(xué)雜志;2011年05期
3 侯健,周帆,張永貞,景燕;硼替佐米治療復(fù)發(fā)、難治性多發(fā)性骨髓瘤[J];中國新藥與臨床雜志;2005年07期
4 袁振剛;侯健;周帆;王東星;付衛(wèi)軍;陳玉寶;奚昊;楊盛玲;;硼替佐米聯(lián)合地塞米松治療16例復(fù)發(fā)、難治性多發(fā)性骨髓瘤患者[J];中華血液學(xué)雜志;2006年10期
5 高沖;陳寶安;孫耘玉;程堅(jiān);費(fèi)菲;;硼替佐米為主方案治療復(fù)發(fā)難治性多發(fā)性骨髓瘤[J];白血病.淋巴瘤;2007年04期
6 段明輝;周道斌;韓冰;李劍;鄒農(nóng);張薇;朱鐵楠;趙永強(qiáng);武永吉;;硼替佐米治療12例難治性多發(fā)性骨髓瘤[J];白血病.淋巴瘤;2007年05期
7 謝亞萍;錢R季,
本文編號(hào):2315026
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2315026.html
最近更新
教材專著